{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:15:09Z","timestamp":1772806509726,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11845-024-03792-5","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:54:32Z","timestamp":1724435672000},"page":"3071-3076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular diagnosis of Alpha-sarcoglycanopathies by NGS in seven Moroccan families and report of two novel variants"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-5345","authenticated-orcid":false,"given":"Yasmina","family":"Rahmuni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef El","family":"Kadiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber","family":"Lyahyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelaziz","family":"Sefiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilham","family":"Ratbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"issue":"4","key":"3792_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.36185\/2532-1900-024","volume":"39","author":"C Angelini","year":"2020","unstructured":"Angelini C (2020) LGMD Identification, description and classification. Acta Myol 39(4):207\u2013217. https:\/\/doi.org\/10.36185\/2532-1900-024","journal-title":"Acta Myol"},{"issue":"10","key":"3792_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.nmd.2021.07.014","volume":"31","author":"M Vainzof","year":"2021","unstructured":"Vainzof M, Souza LS, Gurgel-Giannetti J, Zatz M (2021) Sarcoglycanopathies: an update. Neuromusc Disord 31(10):1021\u20131027. https:\/\/doi.org\/10.1016\/j.nmd.2021.07.014","journal-title":"Neuromusc Disord"},{"key":"3792_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1051\/medsci\/2020243","volume":"36","author":"G Fern\u00e1ndez-Eulate","year":"2020","unstructured":"Fern\u00e1ndez-Eulate G, Leturcq F, Lafor\u00eat P et al (2020) Les sarcoglycanopathies: \u00c9tat des lieux et perspectives th\u00e9rapeutiques. Med Sci (Paris) 36:22\u201327. https:\/\/doi.org\/10.1051\/medsci\/2020243","journal-title":"Med Sci (Paris)"},{"issue":"9","key":"3792_CR4","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awaa228","volume":"143","author":"J Alonso-P\u00e9rez","year":"2020","unstructured":"Alonso-P\u00e9rez J and others (2020) New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy. Brain 143(9):2696\u20132708. https:\/\/doi.org\/10.1093\/brain\/awaa228","journal-title":"Brain"},{"issue":"4","key":"3792_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2741\/4418","volume":"21","author":"J Berger","year":"2016","unstructured":"Berger J (2016) The sarcoglycan complex in skeletal muscle. Front Biosci 21(4):744\u2013756. https:\/\/doi.org\/10.2741\/4418","journal-title":"Front Biosci"},{"issue":"5","key":"3792_CR6","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/ijms22052502","volume":"22","author":"C S\u00e1nchez Riera","year":"2021","unstructured":"S\u00e1nchez Riera C, Lozanoska-Ochser B, Testa S et al (2021) Muscle Diversity, Heterogeneity, and Gradients: Learning from Sarcoglycanopathies. IJMS 22(5):2502. https:\/\/doi.org\/10.3390\/ijms22052502","journal-title":"IJMS"},{"key":"3792_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fneur.2017.00322","volume":"8","author":"H Tai","year":"2017","unstructured":"Tai H and others (2017) Correlation of creatine Kinase levels with clinical features and survival in amyotrophic lateral sclerosis. Front. Neurol 8:322. https:\/\/doi.org\/10.3389\/fneur.2017.00322","journal-title":"Front. Neurol"},{"issue":"3","key":"3792_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1155\/S1110724302205069","volume":"2","author":"A Sbiti","year":"2002","unstructured":"Sbiti A, El Kerch F, Sefiani A (2002) Analysis of Dystrophin Gene Deletions by Multiplex PCR in Moroccan patients. J Biomed Biotechnol 2(3):158\u2013160. https:\/\/doi.org\/10.1155\/S1110724302205069","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"3792_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/gtmb.2013.0326","volume":"18","author":"F El Kerch","year":"2014","unstructured":"El Kerch F, Ratbi I, Sbiti A et al (2014) Carrier frequency of the c.525delT Mutation in the SGCG Gene and estimated prevalence of limb girdle muscular Dystrophy Type 2C among the moroccan population. Gen Test Mole Biomarkers 18(4):253\u2013256. https:\/\/doi.org\/10.1089\/gtmb.2013.0326","journal-title":"Gen Test Mole Biomarkers"},{"issue":"2","key":"3792_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/humu.21659","volume":"33","author":"T Soheili","year":"2012","unstructured":"Soheili T and others (2012) Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications. Hum Mutat 33(2):429\u2013439. https:\/\/doi.org\/10.1002\/humu.21659","journal-title":"Hum Mutat"},{"issue":"12","key":"3792_CR11","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/acn3.649","volume":"5","author":"BRR Nallamilli","year":"2018","unstructured":"Nallamilli BRR and others (2018) Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol 5(12):1574\u20131587. https:\/\/doi.org\/10.1002\/acn3.649","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"3792_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jmg.34.6.470","volume":"34","author":"A Carrie","year":"1997","unstructured":"Carrie A and others (1997) Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Gen 34(6):470\u2013475. https:\/\/doi.org\/10.1136\/jmg.34.6.470","journal-title":"J Med Gen"},{"issue":"1","key":"3792_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-019-1021-9","volume":"14","author":"Z Xie","year":"2019","unstructured":"Xie Z and others (2019) Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients. Orphanet J Rare Dis 14(1):43. https:\/\/doi.org\/10.1186\/s13023-019-1021-9","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3792_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/brain\/awab301","volume":"145","author":"J Alonso-P\u00e9rez","year":"2022","unstructured":"Alonso-P\u00e9rez J and others (2022) Clinical and genetic spectrum of a large cohort of patients with \u03b4-sarcoglycan muscular dystrophy. Brain 145(2):596\u2013606. https:\/\/doi.org\/10.1093\/brain\/awab301","journal-title":"Brain"},{"issue":"7","key":"3792_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.nmd.2017.02.011","volume":"27","author":"J Marsolier","year":"2017","unstructured":"Marsolier J and others (2017) 1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15\u201316 November 2016, Evry France. Neuromusc Disord 27(7):683\u2013692. https:\/\/doi.org\/10.1016\/j.nmd.2017.02.011","journal-title":"Neuromusc Disord"},{"issue":"4","key":"3792_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mus.25094","volume":"54","author":"HM Reddy","year":"2016","unstructured":"Reddy HM and others (2016) Homozygous nonsense mutation in SGCA is a common cause of limb-girdle muscular dystrophy in Assiut, Egypt: LGMD in Egypt Linked to SGCA. Muscle Nerve 54(4):690\u2013695. https:\/\/doi.org\/10.1002\/mus.25094","journal-title":"Muscle Nerve"},{"issue":"5","key":"3792_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nmd.2006.02.007","volume":"16","author":"K Fendri","year":"2006","unstructured":"Fendri K, Kefi M, Hentati F, Amouri R (2006) Genetic heterogeneity within a consanguineous family involving the LGMD 2D and the LGMD 2C genes. Neuromuscular Disorders 16(5):316\u2013320. https:\/\/doi.org\/10.1016\/j.nmd.2006.02.007","journal-title":"Neuromuscular Disorders"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03792-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03792-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:25:40Z","timestamp":1734956740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03792-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3792"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03792-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"1 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Rabat ethics committee for Biomedical research (Approval Number: CERB-37\u201323).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants (or their parents) included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}